Want to join the conversation?
Biotechnology company $SPPI said the U.S. Food and Drug Administration has accepted EOquin (apaziquone for intravesical instillation) New Drug Application for review. EOquin is a drug developed for treatment of non-invasive bladder cancer.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.